<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01939288</url>
  </required_header>
  <id_info>
    <org_study_id>JROHH0324</org_study_id>
    <nct_id>NCT01939288</nct_id>
  </id_info>
  <brief_title>Effect of Neuromuscular Calf Stimulation and Intermittent Pneumatic Compression on Lower Limb Venous Hemodynamics</brief_title>
  <official_title>Effect of Neuromuscular Calf Stimulation and Intermittent Pneumatic Compression on Lower Limb Venous Hemodynamics</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Imperial College London</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Imperial College London</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      What is known?

        -  Disorders of peripheral circulation result in vascular morbidity and mortality

        -  Augmentation of peripheral circulation has been shown to be of benefit in both venous
           and arterial disease

        -  The benefit of intermittent pneumatic compression is clinically well evidenced.

        -  The use of intermittent pneumatic compression is limited by compliance issues related to
           sleeve application and external power source.

      What new information will this trial contribute?

      - This evaluates the haemodynamic effect of a new electrical device for augmentation of
      peripheral circulation
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      RATIONALE - Enhancement of peripheral circulation has been shown to be of benefit in many
      vascular disorders, and the clinical effectiveness of intermittent pneumatic compression
      (IPC) is well established in peripheral vascular disease.

      OBJECTIVE - This study aims to compare the haemodynamic efficacy of a novel neuromuscular
      electrical stimulation (NMES) device with IPC in healthy subjects.

      METHODS - 10 healthy volunteers will be randomised into two groups, in an interventional
      cross-over trial. Baseline measurements of haemodynamic velocity and flow will be taken, then
      subjects given bilateral therapy with each of the two devices in turn. Laser doppler
      fluximetry readings will be taken from the hand and foot. Baseline readings will be compared
      with readings taken after immediate cessation of therapy, and after 10 minutes. Tolerability
      will be measured using a verbal reported score.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 2012</start_date>
  <completion_date type="Actual">December 2013</completion_date>
  <primary_completion_date type="Actual">December 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>IPC(on) Peak Velocity Change From Baseline</measure>
    <time_frame>One day</time_frame>
    <description>Ultrasound measurements of peak velocity. This is taken from the left leg superficial femoral vein and artery</description>
  </primary_outcome>
  <other_outcome>
    <measure>NMES(on) Peak Velocity Change From Baseline</measure>
    <time_frame>One day</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">10</enrollment>
  <condition>Intermittent Pneumatic Compression</condition>
  <arm_group>
    <arm_group_label>Group 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Half of recruited subjects (n=5)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Other half of recruited subjects (n=5)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Neuromuscular stimulation, followed by intermittent pneumatic compression</intervention_name>
    <arm_group_label>Group 1</arm_group_label>
    <other_name>Device 1 followed by a break, followed by device 2</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Intermittent pneumatic compression, followed by neuromuscular stimulation</intervention_name>
    <arm_group_label>Group 2</arm_group_label>
    <other_name>Device 2, followed by a short break then device 2</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria

        Age &gt;18 yrs, Body Mass Index (BMI) 17-30Kg/m2

        Exclusion Criteria

        History of heart disease or respiratory disorder, pregnancy, history of peripheral vascular
        disease or previous thromboembolic event, ABPI&lt; 0.9, cardiac pacemaker, history of leg
        fractures and/or presence of metal implants in the leg, long distance travel within one
        week prior to study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kate Williams</last_name>
    <role>Principal Investigator</role>
    <affiliation>Imperial College London</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Academic Vascular Surgery, Charing Cross Hospital</name>
      <address>
        <city>London</city>
        <zip>W6 8RF</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <link>
    <url>http://www.imperial.ac.uk/people/k.williams</url>
    <description>PI information</description>
  </link>
  <results_reference>
    <citation>Williams KJ, Moore HM, Davies AH. Haemodynamic changes with the use of neuromuscular electrical stimulation compared to intermittent pneumatic compression. Phlebology. 2015 Jun;30(5):365-72. doi: 10.1177/0268355514531255. Epub 2014 Apr 10.</citation>
    <PMID>24722790</PMID>
  </results_reference>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>August 8, 2013</study_first_submitted>
  <study_first_submitted_qc>September 5, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 11, 2013</study_first_posted>
  <results_first_submitted>May 9, 2014</results_first_submitted>
  <results_first_submitted_qc>May 8, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">July 22, 2019</results_first_posted>
  <last_update_submitted>September 19, 2019</last_update_submitted>
  <last_update_submitted_qc>September 19, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">September 20, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>neuromuscular stimulation</keyword>
  <keyword>intermittent pneumatic compression</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Group 1</title>
          <description>Half of recruited subjects (n=5)
Neuromuscular stimulator followed by IPC</description>
        </group>
        <group group_id="P2">
          <title>Group 2</title>
          <description>Other half of recruited subjects (n=5)
IPC followed by neuromuscular stimulator</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="5"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="5"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Healthy</population>
      <group_list>
        <group group_id="B1">
          <title>Group 1</title>
          <description>Half of recruited subjects (n=5)
Neuromuscular stimulator followed by IPC</description>
        </group>
        <group group_id="B2">
          <title>Group 2</title>
          <description>Other half of recruited subjects (n=5)
IPC followed by neuromuscular stimulator</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="5"/>
            <count group_id="B2" value="5"/>
            <count group_id="B3" value="10"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="27.1" spread="3.8"/>
                    <measurement group_id="B2" value="27.1" spread="3.8"/>
                    <measurement group_id="B3" value="27.1" spread="3.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="4"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>IPC(on) Peak Velocity Change From Baseline</title>
        <description>Ultrasound measurements of peak velocity. This is taken from the left leg superficial femoral vein and artery</description>
        <time_frame>One day</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Overall Summation</title>
            <description>Grouping all subject together so that no one intervention in a certain order skews results</description>
          </group>
        </group_list>
        <measure>
          <title>IPC(on) Peak Velocity Change From Baseline</title>
          <description>Ultrasound measurements of peak velocity. This is taken from the left leg superficial femoral vein and artery</description>
          <units>cm/s</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.2" lower_limit="0.1" upper_limit="16.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>NMES(on) Peak Velocity Change From Baseline</title>
        <time_frame>One day</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Overall Summation</title>
            <description>Grouping all subject together so that no one intervention in a certain order skews results</description>
          </group>
        </group_list>
        <measure>
          <title>NMES(on) Peak Velocity Change From Baseline</title>
          <units>cm/s</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="36.7" lower_limit="18.8" upper_limit="49.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>10 days</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Group 1</title>
          <description>Neuromuscular stimulator</description>
        </group>
        <group group_id="E2">
          <title>Group 2</title>
          <description>Intermittent pneumatic compression</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Miss Katherine Williams</name_or_title>
      <organization>Imperial College London</organization>
      <phone>020 3311 7335</phone>
      <email>k.williams@imperial.ac.uk</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

